SCHEMBL7051812

SCHEMBL7051812

C=CC(=O)C=C(O)C=Cc1cc(O)c(O)c(OC)c1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JUN P05412 1/20 0.59
CYP1A2 P05177 2/20 0.57
CYP2D6 P10635 2/20 0.57
CYP3A4 P08684 1/20 0.57
CYP2C9 P11712 1/20 0.57
CYP2B6 P20813 1/20 0.57
PKM P14618 2/20 0.56
PTGS1 P23219 2/20 0.56
PTGS2 P35354 1/20 0.56
GSK3B P49841 3/20 0.55
BACE1 P56817 3/20 0.55
ALOX5 P09917 4/20 0.55
STAT3 P40763 3/20 0.55
NFE2L2 Q16236 3/20 0.55
NFKB1 P19838 2/20 0.55
NFKB2 Q00653 2/20 0.55
RELA Q04206 2/20 0.55
KDM4E B2RXH2 2/20 0.50
GAA P10253 1/20 0.50
HSD11B1 P28845 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6440492 0.90 JUN (0.70) JUNCYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL6440499 0.90 JUN (0.70) JUNCYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL3335463 0.81 CYP1A2 (0.81) JUNCYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL3335467 0.81 CYP1A2 (0.81) JUNCYP1A2CYP2D6CYP3A4CYP2C9
SCHEMBL197850 0.79 PKM (0.87) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL10085810 0.79 PKM (0.87) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL29537849 0.79 PKM (0.87) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL561928 0.76 CYP2D6 (0.67) CYP1A2CYP2D6CYP3A4CYP2C9CYP2B6
SCHEMBL608770 0.76 BACE1 (0.70) JUNCYP1A2CYP2D6GSK3BBACE1
SCHEMBL3433171 0.76 GSK3B (0.87) JUNCYP1A2CYP2D6CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030216600-A1 Novel polyhydroxy curcumins having antioxidant activity LAILA IMPEX (IN) 2003-11-20 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030216600-A1 Novel polyhydroxy curcumins having antioxidant activity DBH, KEAP1, HMOX1 JUN 966/4885CYP1A2 725/4885CYP2D6 1068/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.